Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Nephrocare Health Services Ltd (NEPHROPLUS) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
India Dialysis ServicesIn-center haemodialysis, home dialysis, mobile dialysis, pharmacy supportLeading brand, extensive network, standardized protocols, economies of scaleB2C chronic kidney disease patients, government hospitals under PPPStandalone and captive clinics with optimized operations51568Fee-for-service from recurring dialysis treatments, revenue-share PPP clinics, pharmacy salesPer-treatment fees, some long-term contracts in PPP segmentsIncreasing dialysis penetration in India, PPP partnerships, expanding Tier 2/3 city networkNephroPlus Clinics, PPP clinics
International Dialysis ServicesClinic-based dialysis, mobile home dialysis servicesFirst Indian dialysis network scaling internationally, replicable low-cost operating model, strategic partnershipsB2C patients across emerging dialysis markets with reimbursement schemesNewly acquired networks and large flagship clinics with PPP contracts24032Per-treatment fees, acquisitions with established patient basesFee-for-service with higher pricing in international marketsMarket expansion, higher treatment prices, acquisitions in growing CKD marketsClinics in Philippines, Uzbekistan, Nepal, Saudi Arabia

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions